Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma

Abstract

Introduction: A new arm of the renin–angiotensin system (RAS) has been recently characterized; this includes angiotensin converting enzyme (ACE)2 and angiotensin (Ang)1-7, a heptapeptide acting through the Mas receptor (MasR). Recent studies show that Ang1-7 has an antiproliferative action on lung adenocarcinoma cells. The aim of this study was to characterize RAS expression in human colon adenocarcinoma and to investigate whether Ang1-7 exerts an antiproliferative effect on human colon adenocarcinoma cells.

Materials and methods: Gene, protein expression and enzymatic activity of the main components of the RAS were determined on non-neoplastic colon mucosa as well as on the tumor mass and the mucosa taken 5 cm distant from it, both collected from patients with colon adenocarcinoma. Two different human colon cancer cell lines were treated with AngII and Ang1-7.

Results: The novel finding of this study was that MasR was significantly upregulated in colon adenocarcinoma compared with non-neoplastic colon mucosa, which showed little or no expression of it. ACE gene expression and enzymatic activity were also increased in the tumors. However, AngII and Ang1-7 did not have any pro-/antiproliferative effects in the cell lines studied.

Conclusions: The data suggest that upregulation of the MasR could be used as a diagnostic marker of colon adenocarcinoma.

Keywords

Angiotensin converting enzyme-2 angiotensin 1-7 cell cycle cell lines colon adenocarcinoma Mas receptor oncogene renin–angiotensin system

Get full access to this article

View all access options for this article.

References

Raizada

Ferreira

. ACE2: a new target for cardiovascular disease therapeutics. J Cardiovasc Pharmacol 2007; 50: 112–119.

Freeman

Chisolm

Ferrario

Tallant

. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996; 28: 104–108.

Tallant

Diz

Ferrario

. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension 1999; 34: 950–957.

Tallant

Clark

. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 2003; 42: 574–579.

Gallagher

Tallant

. Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 2004; 25: 2045–2052.

Menon

Soto-Pantoja

Callahan

. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res 2007; 67: 2809–2815.

Soto-Pantoja

Menon

Gallagher

Tallant

. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther 2009; 8: 1676–1683.

Neo

Ager

Angus

Zhu

Herath

Christophi

. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases. BMC Cancer 10: 134.

Santos

Krieger

Greene

. An improved fluorometric assay of rat serum and plasma converting enzyme. Hypertension 1985; 7: 244–252.

10.

Herath

Warner

Lubel

. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 2007; 47: 387–395.

11.

Barton

Carmona

Morawietz

. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension 2000; 35: 329–336.

12.

Burrell

Risvanis

Kubota

. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 2005; 26: 369–375; discussion 322–364.

13.

Burchill

Velkoska

Dean

. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Exp Physiol 2008; 93: 622–630.

14.

Velkoska

Dean

Griggs

Burchill

Burrell

. Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. Clin Sci (Lond) 2011; 120: 335–345.

15.

Thomas

Pickering

Tsorotes

. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 2010; 107: 888–897.

16.

Talero

Sanchez-Fidalgo

Villegas

Lastra

Illanes

Motilva

. Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis 2011; 17: 696–710.

17.

Fasano

Birnbaum

Edlund

Fogh

Wigler

. New human transforming genes detected by a tumorigenicity assay. Mol Cell Biol 1984; 4: 1695–1705.

18.

Young

Waitches

Birchmeier

Fasano

Wigler

. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 1986; 45: 711–719.

19.

Croce

. Oncogenes and cancer. N Engl J Med 2008; 358: 502–511.

20.

Rodgers

Xiong

Felix

. Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regen 2001; 9: 238–247.

21.

Ellefson

diZerega

Espinoza

Roda

Maldonado

Rodgers

. Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice. Cancer Chemother Pharmacol 2004; 53: 15–24.

22.

Alenina

Rentzsch

Patkin

Bader

. Genetically altered animal models for Mas and angiotensin-(1-7). Exp Physiol 2008; 93: 528–537.